EMA Authorised: Cialis (tadalafil) — Eli Lilly Nederland B.V.

View source ↗

Summary

EMA authorised Cialis (tadalafil) for erectile dysfunction, with Eli Lilly Nederland B.V. as the marketing authorisation holder; decision dated 27 January 2026.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erectile Dysfunction

Drugs mentioned

• Cialis (tadalafil)

Snippet

Status: Authorised. Therapeutic area: Erectile Dysfunction. MAH: Eli Lilly Nederland B.V.. Decision date: 27/01/2026